Bon-Hong Min

Title: Bon-Hong Min: Innovator in Pharmaceutical Composition

Introduction

Bon-Hong Min is a notable inventor based in Hanam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of angiogenesis inhibition. His work focuses on developing innovative solutions that can potentially improve therapeutic outcomes for various medical conditions.

Latest Patents

Bon-Hong Min holds a patent for a pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis. The invention relates to a pharmaceutical composition that utilizes arginine deiminase as an active ingredient. This enzyme, which can be obtained through genetic recombination techniques, may be conjugated to an activated polymer to reduce its immunogenicity and extend its lifespan. The pharmaceutical composition demonstrates excellent inhibitory activity against angiogenesis, showcasing its potential in medical applications.

Career Highlights

Bon-Hong Min is currently associated with Angiolab, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the pharmaceutical industry, particularly in the development of treatments that target angiogenesis.

Collaborations

He collaborates with esteemed colleagues such as Myung-Ok Park and Min-Young Kim, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Bon-Hong Min's contributions to pharmaceutical science, particularly through his patent on arginine deiminase, highlight his role as an influential inventor. His ongoing work at Angiolab, Inc. continues to pave the way for advancements in medical treatments.